Publications
View relevant research articles from members of the DIADEM team.
Hardy, C.J.D., Hwang, Y.T., Bond, R.L., Marshall, C.R., Ridha, B.H., Crutch, S.J., Rossor, M.N. and Warren, J.D. (2017). Donepezil enhances understanding of degraded speech in Alzheimer’s disease. Annals of Clinical and Translational Neurology, 4(11), pp.835–840. doi:https://doi.org/10.1002/acn3.471.
Hardy, C.J.D., Marshall, C.R., Golden, H.L., Clark, C.N., Mummery, C.J., Griffiths, T.D., Bamiou, D.-E. and Warren, J.D. (2016). Hearing and dementia. Journal of Neurology, 263(11), pp.2339–2354. doi:https://doi.org/10.1007/s00415-016-8208-y.
Hardy, C.J.D., Yong, K.X.X., Goll, J.C., Crutch, S.J. and Warren, J.D. (2020). Impairments of auditory scene analysis in posterior cortical atrophy. Brain, 143(9), pp.2689–2695. doi:https://doi.org/10.1093/brain/awaa221.
Jiang, J., Benhamou, E., Waters, S., Johnson, J.C.S., Volkmer, A., Weil, R.S., Marshall, C.R., Warren, J.D. and Hardy, C.J.D. (2021). Processing of Degraded Speech in Brain Disorders. Brain Sciences, 11(3), p.394. doi:https://doi.org/10.3390/brainsci11030394.
Jiang, J., Johnson, J.C.S., Maï-Carmen Requena-Komuro, Benhamou, E., Harri Sivasathiaseelan, Anthipa Chokesuwattanaskul, Nelson, A., Nortley, R., Weil, R.S., Volkmer, A., Marshall, C.R., Doris-Eva Bamiou, Warren, J.D. and Hardy, C.J.D. (2023). Comprehension of acoustically degraded speech in Alzheimer’s disease and primary progressive aphasia. Brain, 146(10), pp.4065–4076. doi:https://doi.org/10.1093/brain/awad163.
Johnson, J.C.S., Marshall, C.R., Weil, R.S., Bamiou, D.-E., Hardy, C.J.D. and Warren, J.D. (2020). Hearing and dementia: from ears to brain. Brain, 144(2), pp.391–401. doi:https://doi.org/10.1093/brain/awaa429.
Keshavan, A., Pannee, J., Karikari, T.K., Rodriguez, J.L., Ashton, N.J., Nicholas, J.M., Cash, D.M., Coath, W., Lane, C.A., Parker, T.D., Lu, K., Buchanan, S.M., Keuss, S.E., James, S.-N., Murray-Smith, H., Wong, A., Barnes, A., Dickson, J.C., Heslegrave, A. and Portelius, E. (2021). Population-based blood screening for preclinical Alzheimer’s disease in a British birth cohort at age 70. Brain: A Journal of Neurology, 144(2), pp.434–449. doi:https://doi.org/10.1093/brain/awaa403.